Home>Drug Target Models>Class A(Rhodopsin)

DRD3

DRD3 is a dopamine receptor that couples to Gi/Go-type G proteins to regulate neuronal function. It is mainly distributed in the limbic regions of the central nervous system, modulating mood and motor function, and serves as an important therapeutic target for schizophrenia, drug addiction and Parkinson’s disease. Our DRD3 stable HEK293 cell lines have been validated in cAMP assays to support your drug discovery programs.

Contact us

Name

Phone

Email*

Service & Products Interested*

Comments

submit
info@reqbio.com Email